although forecast sizabl albeit deceler lift march-to-may year
question around benefit durat acceler de-lever effect
magnitud give-back although find well posit captur
driven upsid remain sidelin given two-year forward normal
bit soft at-hom bounc materi forecast fluid throughout
conagra first food compani post result subsequ gener mill two
week ago conagra report result line intern compani expect
slightli lower we/consensu expect sale oper profit ep
line gross op margin compress y/i also real focu howev
compani y/i increas to-dat shipment consumpt
could impli total organ sale growth net declin
foodservic normal revenu base margin given materi
oper leverag like less promot activ off-set nearli
higher wages/bonus increment input cost inflat higher transport
cost assum consumpt y/i step month
march april may get organ sale growth compani
domest retail busi layer expect y/i declin foodservic flat
intern forecast all-in organ sale grow y/i given
forthcom volum leverag weve estim bp potenti gross margin
bp oper margin expans fix expens side sg
provid increment lift op profit net higher wages/bonus input cost
transport forecast fluid throughout quarter close
monitor tracked-channel trend per compani recommend
ep year vs above-the-high-end guid best logic
estim point
flow-through effect could caus undul result next two fiscal year given
much packag food could see consumpt bump post-may at-hom
demand remain elev think extent talk
lift well like much need lap pull-forward
one-time-in-natur benefit seen year-ago get nice at-
home tailwind year like give back next year carryov
effect even bleed next two fiscal year feel impact
increas ep forecast given top-lin bump oper leverag pt
prior increas ep estim
respect account at-hom food consumpt shift albeit deceler
though come august also bump pt slightli improv valuat given
benefit near-term centric food exposur
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
organ sale growth averag
oper margin expand bp
leverag fall
price target price-to-earnings multipl
month forward ep
organ sale growth averag driven
prolong at-hom consumpt trend
leverag fall
price target price-to-earnings multipl
month forward ep
organ sale growth
price target price-to-earnings multipl
forward ep
manag done commend job
improv legaci conagra portfolio taken
appropri step correct execut issu
exist competit remain stiff innov
find well-posit captur
upsid remain sidelin given
retail consumpt trend next six month
pleas see import disclosur inform page report
pleas see import disclosur inform page report
augnovfebmayaugnovfebmayfisc year end may good sale cog sale bp gross gross margin gross margin bpssell gener sg sale sg sale advertis sale sg sale bpstotal oper oper oper margin interest pension postretir non-servic equiti method invest pre-tax incom tax rate earn attribut extraordinari item net incom ep exclud extraordinari share outstand dilut dividend per depreci incom statement y/i exclud extraordinari share per ratio analysi pay-out equiti research
one north america lead brand food compani compani portfolio includ icon brand
bird mari callend banquet healthi choic slim jim reddi-wip vlasic well emerg brand includ angi
boomchickapop duke earth balanc gardein frontera
price target base price-to-earnings multipl ep forecast risk includ consumpt trend impress
concern re-emerg regard top-lin soft hand investor bail valuat contract
rob dickerson certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
matt fishbein certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
ashish mago certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
